Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases

BACKGROUND: Median survival of non-small cell lung cancer (NSCLC) patients with brain metastases is poor. We examined concurrent erlotinib and whole brain radiotherapy (WBRT) followed by maintenance erlotinib in patients with untreated brain metastases, given the potential radiosensitizing propertie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Siow Ming, Lewanski, Conrad R., Counsell, Nicholas, Ottensmeier, Christian, Bates, Andrew, Patel, Nirali, Wadsworth, Christina, Ngai, Yenting, Hackshaw, Allan, Faivre-Finn, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112798/
https://www.ncbi.nlm.nih.gov/pubmed/25031274
http://dx.doi.org/10.1093/jnci/dju151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112798/
https://www.ncbi.nlm.nih.gov/pubmed/25031274
http://dx.doi.org/10.1093/jnci/dju151

Ejemplares similares